Cargando…
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy
Drug resistance, a major challenge in cancer therapy, is typically attributed to mutations and genetic heterogeneity. Emerging evidence suggests that dynamic cellular interactions and group behavior also contribute to drug resistance. However, the underlying mechanisms remain poorly understood. Here...
Autores principales: | Nam, Arin, Mohanty, Atish, Bhattacharya, Supriyo, Kotnala, Sourabh, Achuthan, Srisairam, Hari, Kishore, Srivastava, Saumya, Guo, Linlin, Nathan, Anusha, Chatterjee, Rishov, Jain, Maneesh, Nasser, Mohd W., Batra, Surinder Kumar, Rangarajan, Govindan, Massarelli, Erminia, Levine, Herbert, Jolly, Mohit Kumar, Kulkarni, Prakash, Salgia, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773639/ https://www.ncbi.nlm.nih.gov/pubmed/35053156 http://dx.doi.org/10.3390/biom12010008 |
Ejemplares similares
-
A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer
por: Mohanty, Atish, et al.
Publicado: (2020) -
A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer
por: Mohanty, Atish, et al.
Publicado: (2020) -
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival
por: Amanam, Idoroenyi, et al.
Publicado: (2020) -
Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells
por: Mirzapoiazova, Tamara, et al.
Publicado: (2019) -
Biomarkers in immunotherapy: literature review and future directions
por: Pharaon, Rebecca, et al.
Publicado: (2020)